Top 10 Global Pharmaceutical Company Awards $1.3 Million in Studies to eResearchTechnology for Cardiac Safety Monitoring and Inf
07 July 2005 - 12:01AM
PR Newswire (US)
Top 10 Global Pharmaceutical Company Awards $1.3 Million in Studies
to eResearchTechnology for Cardiac Safety Monitoring and
Information Distribution Services Phase III Program Award
Demonstrates Industry Compliance With Later Phase Development
Aspects of Recently Ratified ICH, E14 Guidance PHILADELPHIA, July 6
/PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT),
(NASDAQ:ERES), a leading provider of centralized
electrocardiographic (ECG) collection and interpretation services,
announced today that it has been awarded more than $1.3 million in
cardiac safety monitoring and services from a top 10 global
pharmaceutical organization for one of its key drug candidates in
late phase clinical trials. The award for the Phase III program and
a related Phase II trial is comprised of a number of studies with
an investigator network that spans five continents. eRT will
provide comprehensive support, including provision of 340 units of
digital 12-lead ECG equipment designed to facilitate collection of
cardiac safety data that is subsequently provided to eRT for
analysis. eRT will perform digital collection, measurement,
interpretation, review, and distribution of cardiac safety data
through its EXPeRT(R) workflow enabled data handling technology,
the first solution in production that was designed explicitly to
meet emerging international regulatory guidance and technical
standards. "This award illustrates industry response to the
recently ratified ICH, E14 guidance, which specifies cardiac safety
monitoring on all compounds in a manner consistent with therapeutic
area standards, regardless of Thorough QT Study results," said
Scott Grisanti, senior vice president of business development and
chief marketing officer at eRT. "In addition, the agreement
recognizes the value drug developers are placing on the ability to
make program level awards to eRT, which offers the Project
Assurance delivery methodology and global logistics and site
support capabilities required to ensure success of this critical
and complex initiative." Based in Philadelphia, PA,
eResearchTechnology, Inc. (http://www.ert.com/) is a provider of
technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis. The company is a
market leader in providing centralized core-diagnostic
electrocardiographic (ECG) technology and services to evaluate
cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the
clinical trials process by enabling its customers to automate the
collection, analysis, and distribution of clinical data in all
phases of clinical development. Statements included in this release
may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
involve a number of risks and uncertainties such as competitive
factors, technological development, market demand, and the
company's ability to obtain new contracts and accurately estimate
net revenues due to variability in size, scope and duration of
projects, and internal issues in the sponsoring client. The sponsor
may cancel this agreement at its sole discretion. As a result,
actual results may differ materially from any financial outlooks
stated herein. Further information on potential factors that could
affect the company's financial results can be found in the
company's Reports on Forms 10-K and 10-Q filed with the Securities
and Exchange Commission. DATASOURCE: eResearchTechnology, Inc.
CONTACT: Joan Sterlacci of eResearchTechnology, +1-908-203-6473, or
Matt Hayden of Hayden Communications, +1-858-704-5065, for
eResearchTechnology Web site: http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Technology Inc. (MM) News Articles